However, President-elect Donald Trump's pick to lead HHS, Robert F
Important Notice : The peptide form of GLP1-S is provided strictly for laboratory research use only
Many authors discuss the inadequacy of guidelines when written based on general consensus and expert opinion, rather than on high-level clinical evidence, noting that case reports, retro/prospective studies, and observational studies, as is mostly what is currently available, are often insufficient to inform clinical practice (Australian Diabetes Society, National Association of Clinical Obesity Services, Gastroenterological Society of Australia, and Australian and New Zealand College of Anaesthetists n.d.)
Injections are more likely to cause injection-site reactions such as redness, itching, or mild swelling
A virtual consultation with a medical provider is required before any peptide prescription is issued
Image: Shutterstock 'Obesity plus': Whats next for GLP-1s